Product logins

Find logins to all Clarivate products below.


Anthem Blue Cross Blue Shield has pulled out of Nevada's Medicaid program, citing low reimbursements and little prospect of improvement given the state's strained budget. AMERIGROUP has jumped in to fill the void, though.

Nevada's recent economic growth has been choked off by the national economic downturn, and carriers have been busy creating and packaging individual products to meet demand from cost-conscious buyers.

Sierra Health, now owned by UnitedHealth, is offering a new value-based drug option in its popular Medicare Advantage plan, hoping to score with seniors who value a no-copay policy for the drugs that keep them stabilized.

Nevada's insurers are trying a range of different tactics to control costs of specialty drugs and the cost of radiology services.

Humana is moving aggressively to maximize its opportunities in Nevada as UnitedHealth has had to part from its Las Vegas MA business in order to merge with Sierra.

Related Market Access Reports

Report
Universal Health Services, Nevada | State IDN Profile
IDN Profiles are part of Healthbase, which is an innovative platform that helps multi-disciplinary market access teams navigate the complex healthcare ecosystem with the affiliations data and insights
Report
HCA Healthcare, Nevada | State IDN Profile
IDN Profiles are part of Healthbase, which is an innovative platform that helps multi-disciplinary market access teams navigate the complex healthcare ecosystem with the affiliations data and insights
Report
Las Vegas, Nevada | Market Overview Brief
Market Overview Briefs are Powerpoint slide presentations offering a condensed version of Market Overview reports.
Report
Las Vegas, Nevada | Market Overview
Market Overview analyzes 87 metro area healthcare market dynamics, including top providers and payers. Market Overview includes MO Advanced Dashboard for segmenting and comparing markets. In 2023,
Report
Nevada | 2026 | Medicaid Profile | National MCO Analyzer
State Medicaid Profiles offer a dashboard of key MCO players and enrollment, recent policy actions, and pharmacy trends for all 50 states, the District of Columbia, and Puerto Rico. Sections most